Cargando…

P602: SINGLE-CELL RNA-SEQUENCING ENABLES TRACKING AND CHARACTERIZATION OF RARE CLL CELLS WITH THE POTENTIAL TO CAUSE REFRACTORINESS.

Detalles Bibliográficos
Autores principales:	Kurucová, Terézia, Réblová, Kamila, Vališová, Martina, Paweł Porc, Jakub, Navrkalová, Veronika, Pavlová, Šárka, Malčíková, Jitka, Plevová, Karla, Tichý, Boris, Doubek, Michael, Kotašková, Jana, Pospíšilová, Šárka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429134/ http://dx.doi.org/10.1097/01.HS9.0000969312.16660.f0

Ejemplares similares

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
por: Olbertova, Helena, et al.
Publicado: (2022)

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
por: Malcikova, Jitka, et al.
Publicado: (2021)

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia
por: Kminkova, Jana, et al.
Publicado: (2014)

Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage
por: Mancikova, Veronika, et al.
Publicado: (2022)

Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL
por: Brazdilova, K, et al.
Publicado: (2018)

Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application
por: Hynst, Jakub, et al.
Publicado: (2021)

CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
por: Hernández-Sánchez, María, et al.
Publicado: (2018)

Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
por: Taus, Petr, et al.
Publicado: (2021)

ToTem: a tool for variant calling pipeline optimization
por: Tom, Nikola, et al.
Publicado: (2018)

Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells
por: Dave, Zankruti, et al.
Publicado: (2022)

Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia
por: Plešingerová, Hana, et al.
Publicado: (2018)

Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene
por: Poppova, Lucie, et al.
Publicado: (2022)

A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome
por: Skalníková, Magdalena, et al.
Publicado: (2022)

Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants
por: Hynst, Jakub, et al.
Publicado: (2019)

Editorial: Biology and treatment of high-risk CLL
por: Tausch, Eugen, et al.
Publicado: (2023)

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?
por: Edelmann, Jennifer, et al.
Publicado: (2023)

A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia
por: Doubková, Martina, et al.
Publicado: (2019)

Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons
por: Rodríguez-Vicente, Ana E., et al.
Publicado: (2017)

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
por: Malcikova, J, et al.
Publicado: (2015)

Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
por: Kubesova, B, et al.
Publicado: (2018)

S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
por: Ondrisova, Laura, et al.
Publicado: (2023)

Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report
por: Doubková, Martina, et al.
Publicado: (2019)

Very rare near‐haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR‐T therapy in 19‐year‐old male patient
por: Arpas, Tomas, et al.
Publicado: (2022)

RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model
por: Svozilová, Hana, et al.
Publicado: (2021)

The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia
por: Urazbakhtin, Shamil, et al.
Publicado: (2022)

Completion of R602
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1973)

Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome
por: Doubková, Martina, et al.
Publicado: (2023)

Who is who in R602
por: Baum, L, et al.
Publicado: (1973)

Poster Sessions 602-806
Publicado: (2004)

A Complex Role for FGF-2 in Self-Renewal, Survival, and Adhesion of Human Embryonic Stem Cells
por: Eiselleova, Livia, et al.
Publicado: (2009)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
por: Odetola, Oluwatobi, et al.
Publicado: (2023)

602 Cvid: A Common but Still Underdiagnosed Disease
por: Gallego, Claudia, et al.
Publicado: (2012)

Binding of Histone H1 to DNA Is Differentially Modulated by Redox State of HMGB1
por: Polanská, Eva, et al.
Publicado: (2014)

Procedure d’acces porte 602
Publicado: (1986)

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
por: Siddiqi, Tanya, et al.
Publicado: (2022)

Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL
por: Agrawal, Rohitashva, et al.
Publicado: (2020)

Attenuation of vaccinia virus by the expression of human Flt3 ligand
por: Zurkova, Kamila, et al.
Publicado: (2010)

HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIα
por: Štros, Michal, et al.
Publicado: (2009)

Histone H1 Differentially Inhibits DNA Bending by Reduced and Oxidized HMGB1 Protein
por: Štros, Michal, et al.
Publicado: (2015)

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
por: Lobello, Cosimo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8lqc1h69jelqv3fnu660hcfn0j